Le Lézard
Classified in: Business
Subject: ATY

(AIMT) Alert: Johnson Fistel Investigates Proposed Sale of Aimmune Therapeutics; Is $34.50 a Fair Price?


SAN DIEGO, Aug. 31, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Aimmune Therapeutics, Inc. ("Aimmune" or the "Company") (NASDAQ: AIMT) breached their fiduciary duties in connection with the proposed sale of the Company to Nestlé S.A. 

On August 31, 2020, Aimmune announced that it had entered into a definitive merger agreement with Nestlé S.A. Under the terms of the acquisition agreement, the Company's shareholders will receive $34.50 per share in cash.

The investigation concerns whether the Aimmune board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Aimmune shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given one Wall Street analyst has a $66.00 price target on the stock. The 52-week high for Aimmune was $37.00.

If you are a shareholder of Aimmune and believe the proposed buyout price is too low or you're interested in learning more about the investigation, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

Additionally, you can [Click here to join this action]. There is no cost or obligation to you.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

[Click here to join this action]

SOURCE Johnson Fistel, LLP


These press releases may also interest you

at 10:41
Dale Sorensen Real Estate (DSRE) is excited to announce that Vista Florida Realty has merged with DSRE Brevard.  The merger, which brings together two highly successful Brevard County brokerages, will give the companies a distinct advantage in the...

at 10:38
"With asset growth of close to 70% over the past 5 years, DGAM is at a crossroads. As fund manager for Desjardins Group entities including the Desjardins Group Pension Plan, Desjardins Financial Security, Desjardins General Insurance Group and...

at 10:37
Perrigo Company plc , a leading global provider of Quality, Affordable Self-Care Products, today announced that its Board of Directors declared a quarterly dividend of $0.225 per share, payable on December 15, 2020 to shareholders of record on...

at 10:35
Natural gas could be the single most important energy source of the next decade. For investors who want both profitability and longevity, the natural gas sector is the very first place to look.  The math is simple: Big banks are fleeing oil. The coal...

at 10:34
SPAC Analytics, a long established leading provider of data and research for Special Purpose Acquisition Companies (SPACs) is pleased to release a new homepage with an expanded set of data that unveils many interesting findings. 2020 is the breakout...

at 10:31
The strategic consulting industry has changed drastically in recent times. Now more than ever, consulting companies need to think outside established standards and reinvent themselves in ever-changing environments. As a result, digital acceleration...



News published on 31 august 2020 at 07:37 and distributed by: